House Resolution Affirms FDA Authority to Approve Abortion Drugs like Mifepristone.
This House Resolution expresses the view that the Food and Drug Administration (FDA) has the full authority to approve drugs used for abortion care, such as Mifepristone. Citizens should understand that Congress believes FDA decisions, based on science and safety, must be respected, and federal court attempts to overturn them violate the intent of the law. The resolution emphasizes that access to Mifepristone, used in over half of abortions nationwide, is vital for the reproductive healthcare of millions of Americans.
Key points
Affirmation: Congress intended for the FDA, as the expert body, to have the sole authority to review and approve drugs, including those for abortion care.
Drug Safety: Highlighting that Mifepristone is safe and effective (over 99% safety record) and has been used by over 5 million people since 2000.
Judicial Review: The resolution opposes federal courts attempting to independently review the scientific evidence of drug safety, which poses a threat to other FDA-regulated products.
Reproductive Rights: Stressing that all people in the U.S. should have the ability to make decisions about their reproductive healthcare, including abortion.
Expired
Citizen Poll